[ Price : $8.95]
A bipartisan group of U.S. Senators and House members call on FDA to step up its regulatory activities to improve rare disease pro...[ Price : $8.95]
FDA approves Astellas Pharmas Veozah (fezolinetant), an oral drug for treating moderate-to-severe vasomotor symptoms caused by men...[ Price : $8.95]
Due to its authority having expired on 5/11 with the end of the Covid-10 public health emergency (PHE), FDA now urges medical devi...[ Price : $8.95]
FDA eases its recommendations for evaluating potential blood donors for HIV.[ Price : $8.95]
FDA says a Cook Medical 4/7 recall of a tracheostomy introducer is Class 1.[ Price : $8.95]
FDA approves an Otsuka Pharmaceutical and Lundbeck supplemental NDA for Rexulti (brexpriprazole) oral tablets for treating agitati...[ Price : $8.95]
Three stakeholder groups and seven individuals call for FDA to promptly approve a Knowledge Ecology International 2020 petition to...[ Price : $8.95]
FDA commissioner Robert Califf and chief medical officer Hilary Marston describe ways the agency will be better able to address fu...